UPDATE: UBS Starts Tenet Healthcare (THC) at Neutral

September 23, 2021 4:46 PM EDT
Get Alerts THC Hot Sheet
Price: $63.56 +1.79%

Rating Summary:
    16 Buy, 11 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 13 | New: 72
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Updated - September 24, 2021 4:41 AM EDT)

UBS analyst Andrew Mok initiates coverage on Tenet Healthcare (NYSE: THC) with a Neutral rating, PT $83.00.

The analyst comments "We think a spin of THC’s revenue cycle management business, Conifer, could be a meaningful value-creation event, but it’s difficult to say and we don’t have enough conviction at this point to value the stock on a SOTP basis. While our analysis of precedent transactions suggests that a spin would be a value-creating event, there's an equally compelling argument that investors will not value the RemainCo on a SOTP basis (see EHC, CI, CVS)."

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $73.23 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

UBS